Pregled bibliografske jedinice broj: 938487
Carbamate derivatives of short-acting bronchodilator albuterol inhibits human acetylcholinesterase and butyrylcholinesterase
Carbamate derivatives of short-acting bronchodilator albuterol inhibits human acetylcholinesterase and butyrylcholinesterase // Book of Abstracts of the 10th Congress of Toxicology in Developing Countries and 12th Congress of the serbian Society of Toxicology
Beograd, Srbija, 2018. str. 114-114 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 938487 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Carbamate derivatives of short-acting bronchodilator albuterol inhibits human acetylcholinesterase and butyrylcholinesterase
Autori
Bosak, Anita ; Knežević, Anamarija ; Zlatić, Katarina ; Kerep, Robert ; Kovarik, Zrinka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Book of Abstracts of the 10th Congress of Toxicology in Developing Countries and 12th Congress of the serbian Society of Toxicology
/ - , 2018, 114-114
Skup
10th Congress of Toxicology in Developing Countries (CTDC 10) ; 12th Serbian Congress of Toxicology
Mjesto i datum
Beograd, Srbija, 18.04.2018. - 21.04.2018
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
cholinesterase, selectivity, monocarbamate, biscarbamate, prodrug
Sažetak
Novel synthesised biscarbamate and monocarbamate derivatives of the short-acting bronchodilator albuterol (biscalb) resemble the structure of biscarbamate bambuterol, whose bioconversion to the bronchodilator terbutaline in an organism is enabled through the inhibition of butyrylcholinesterase (BChE). Bambuterol’s high therapeutic index is associated with an extremely selective BChE inhibition compared to acetylcholinesterase (AChE). We determined the inhibition potency of biscalb and monocalb toward human BChE and AChE to evaluate their selectivity. Both carbamates proved to be potent inhibitors of both cholinesterases with ki constants within 103-105 M-1min-1. Biscalb and monocalb inhibited AChE only 10 times slower than they did BChE, meaning that the selectivity of both carbamates was very poor compared to the 20, 000 times faster inhibition of BChE determined for bambuterol. Therefore, the novel compounds lack potential for prodrug development in analogy with bambuterol. However, due to their inhibition potency, these novel carbamates could be considered structural and functional lead compounds for the design of new compounds, whose primary action would be inhibition of cholinesterases, like pesticides or neurodegenerative disease drugs. Supported by CSF Grant no. 4307.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
HRZZ-IP-2013-11-4307 - Dizajn, sinteza i evaluacija novih protuotrova kod trovanja živčanim bojnim otrovima i pesticidima (CHOLINESTERASE) (Kovarik, Zrinka, HRZZ - 2013-11) ( CroRIS)
Profili:
Katarina Zlatić
(autor)
Zrinka Kovarik
(autor)
Anamarija Knežević
(autor)
Anita Bosak
(autor)